- Home
- HMST vs TVGN Comparison
HMST vs TVGN Comparison
Compare HMST & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HMST
- TVGN
- Stock Information
- Founded
- HMST 1921
- TVGN 2020
- Country
- HMST United States
- TVGN United States
- Employees
- HMST N/A
- TVGN N/A
- Industry
- HMST Major Banks
- TVGN Blank Checks
- Sector
- HMST Finance
- TVGN Finance
- Exchange
- HMST Nasdaq
- TVGN Nasdaq
- Market Cap
- HMST 246.0M
- TVGN 193.1M
- IPO Year
- HMST 2012
- TVGN N/A
- Fundamental
- Price
- HMST $13.25
- TVGN $1.24
- Analyst Decision
- HMST Hold
- TVGN Strong Buy
- Analyst Count
- HMST 3
- TVGN 1
- Target Price
- HMST $14.17
- TVGN $10.00
- AVG Volume (30 Days)
- HMST 75.4K
- TVGN 666.6K
- Earning Date
- HMST 07-28-2025
- TVGN 08-13-2025
- Dividend Yield
- HMST N/A
- TVGN N/A
- EPS Growth
- HMST N/A
- TVGN N/A
- EPS
- HMST N/A
- TVGN N/A
- Revenue
- HMST $78,454,000.00
- TVGN N/A
- Revenue This Year
- HMST $161.80
- TVGN N/A
- Revenue Next Year
- HMST $8.90
- TVGN N/A
- P/E Ratio
- HMST N/A
- TVGN N/A
- Revenue Growth
- HMST N/A
- TVGN N/A
- 52 Week Low
- HMST $8.41
- TVGN $0.26
- 52 Week High
- HMST $16.10
- TVGN $3.09
- Technical
- Relative Strength Index (RSI)
- HMST 62.28
- TVGN 51.87
- Support Level
- HMST $13.14
- TVGN $1.19
- Resistance Level
- HMST $13.67
- TVGN $1.27
- Average True Range (ATR)
- HMST 0.35
- TVGN 0.05
- MACD
- HMST 0.07
- TVGN -0.00
- Stochastic Oscillator
- HMST 74.07
- TVGN 70.93
About HMST HomeStreet Inc.
HomeStreet Inc is a commercial bank. It provides commercial loans and consumer loans including mortgage loans, deposit products, private banking, and cash management services. The company loan products include commercial business loans and agriculture loans, consumer loans, single family residential mortgages, loans secured by commercial real estate and construction loans for residential and commercial real estate projects.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.